Elvin Isaac Canas Alvarado, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 119 Kent Dr, Manassas Park, VA 20111 Phone: 571-264-4592 |
News Archive
ITL BioMedical, a division of ITL that sets industry standards for the innovative design and production of biological sampling systems for human and animal use, is pleased to announce that after launching its highly innovative patented DonorCare Needle Guard 2 mid-October the Company has already achieved significant sales in excess of one million products.
Along with the promise that CRISPR-Cas9 gene editing technology can offer new human therapies is the need to ensure its safety. A recent study showed that CRISPR-Cas9 did not produce off-target gene mutations in zebrafish. These results, published in Frontiers in Genetics, confirm previous data in animal models that the risk to the rest of the genome from gene editing is minimal.
The New York Times' "India Ink" blog interviews USAID Administrator Rajiv Shah "on his recent trip to Mumbai about transformations in the development sector, the function of the private sector in development work and the aid agency's new programs and partnerships aimed at reducing preventable child deaths."
The White House plans to ask Congress to increase funding for fighting Medicare fraud by 80 percent, in hopes of curbing billions of dollars in abuses, Dow Jones Newswires/NASDAQ reports. Already, "The administration has stepped up enforcement and prevention efforts targeting Medicare claims. Rather than rely on tips, it has begun combining Medicare claims data into a single, searchable database, making it easier to pinpoint suspicious claims among the more than $1 billion spent on such claims each day" (Burns, 1/28).
InfraScan, a medical device company specializing in brain injury diagnostic products, announced today that it has obtained U.S. Food and Drug Administration approval to market the Infrascanner Model 2000, a noninvasive handheld brain hematoma detector.
› Verified 2 days ago